Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis (MS) - Relapsing-remitting”

257 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 257 results

Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Testing effectiveness (Phase 2)Study completedNCT01071083
What this trial is testing

Treatment Interruption of Natalizumab

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 175
Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Not applicableNot Yet RecruitingNCT07645937
What this trial is testing

Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Hanifi Bal 30
Testing effectiveness (Phase 2)Study completedNCT00203112
What this trial is testing

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

Who this might be right for
Relapse Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 44
Not applicableActive Not RecruitingNCT07757568
What this trial is testing

Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
University of Colorado, Denver 11
Not applicableStudy completedNCT03758820
What this trial is testing

Behavior Cognitive Therapy on Fatigue Impact in MS Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisFatigueCognitive Therapy
Réseau Sep Idf Ouest 105
Not applicableStudy completedNCT04858763
What this trial is testing

MS Relapses During COVID-19 Pandemic

Who this might be right for
Multiple SclerosisCovid19Relapsing Remitting Multiple Sclerosis
Nottingham University Hospitals NHS Trust 51
Testing effectiveness (Phase 2)Study completedNCT00882999
What this trial is testing

Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Eli Lilly and Company 245
Large-scale testing (Phase 3)Active Not RecruitingNCT04688788
What this trial is testing

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 600
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Not applicableStudy completedNCT02010554
What this trial is testing

Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
University of Missouri, Kansas City 40
Not applicableNot Yet RecruitingNCT07827586
What this trial is testing

Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Hoffmann-La Roche 1,800
Testing effectiveness (Phase 2)Study completedNCT01717664
What this trial is testing

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
RedHill Biopharma Limited 18
Large-scale testing (Phase 3)Study completedNCT01442233
What this trial is testing

Plasma Exchanges in Multiple Sclerosis (MS) Relapses

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Acute Relapsing
University Hospital, Bordeaux 38
Testing effectiveness (Phase 2)Study completedNCT00349193
What this trial is testing

Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 306
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07222956
What this trial is testing

Remibrutinib Using MR Imaging in Relapsing or Progressive MS

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Secondary ProgressiveMultiple Sclerosis (MS) Primary Progressive
Moein Amin 20
Post-approval studies (Phase 4)Study completedNCT02471560
What this trial is testing

Tecfidera and the Gut Microbiota

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 36
Post-approval studies (Phase 4)WithdrawnNCT02675413
What this trial is testing

Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Washington University School of Medicine
Not applicableUnknownNCT05705986
What this trial is testing

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Who this might be right for
Relapse Remitting Multiple Sclerosis
Thomas Jefferson University 40
Next Page